Cargando…
Serum Levels of Lipoprotein Lipase Are Increased in Patients with Inflammatory Bowel Disease
Disruption of the lipid profile is commonly found in patients with inflammatory bowel disease (IBD). Lipoprotein lipase (LPL) is a key molecule involved in triglyceride metabolism that plays a significant role in the progression of atherosclerosis. In this study, our aim was to study whether serum L...
Autores principales: | Rodríguez-Hernández, Orvelindo, Carrillo-Palau, Marta, Hernández-Camba, Alejandro, Alonso-Abreu, Inmaculada, Ramos, Laura, de Armas-Rillo, Laura, Martín-González, Candelaria, López-Mejías, Raquel, González-Gay, Miguel Á., Ferraz-Amaro, Iván |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10049227/ https://www.ncbi.nlm.nih.gov/pubmed/36982268 http://dx.doi.org/10.3390/ijms24065194 |
Ejemplares similares
-
Apolipoprotein C3 Is Downregulated in Patients With Inflammatory Bowel Disease
por: Hernández-Camba, Alejandro, et al.
Publicado: (2022) -
The angiopoietin-like protein 4, apolipoprotein C3, and lipoprotein lipase axis is disrupted in patients with rheumatoid arthritis
por: de Armas-Rillo, Laura, et al.
Publicado: (2022) -
Carotid Plaque Assessment Reclassifies Patients with Inflammatory Bowel Disease into Very-High Cardiovascular Risk
por: Hernández-Camba, Alejandro, et al.
Publicado: (2021) -
Insulin Resistance Is Not Increased in Inflammatory Bowel Disease Patients but Is Related to Non-Alcoholic Fatty Liver Disease
por: Carrillo-Palau, Marta, et al.
Publicado: (2021) -
QRISK3 Performance in the Assessment of Cardiovascular Risk in Patients with Inflammatory Bowel Disease
por: Carrillo-Palau, Marta, et al.
Publicado: (2021)